Nypozi Injection
Product Images NDC 69097-430

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Nypozi (NDC 69097-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300mcg (1) 0.5 mL Syringe Carton. (300mcg (1) 0.5 mL Syringe Carton)

NYPOZI 300 mcg/0.5 mL injection prefilled single-dose syringe packaging label by Cipla USA Inc. The label indicates filgrastim-txid as the active ingredient for subcutaneous or intravenous use. The package includes one 300 mcg/0.5 mL syringe with needle guard, instructions on dilution, storage conditions, and ingredients. The design features the NYPOZI logo and Cipla branding.*

FDA Label Image

300mcg (10) 0.5 mL Syringe Carton. (300mcg (10) 0.5 mL Syringe Carton)

Packaging label for NYPOZI (filgrastim-txid) injection 300 mcg/0.5 mL single-dose prefilled syringes. The label indicates subcutaneous or intravenous use with 10 syringes per carton. Manufacturer information includes Tanvex BioPharma USA and Cipla USA Inc. The label details sterile solution ingredients, storage conditions, and usage instructions.*

FDA Label Image

480mcg (1) 0.8 mL Syringe Carton. (480mcg (1) 0.8 mL Syringe Carton)

The label for NYPOZI (filgrastim-txid) injection 480 mcg/0.8 mL single-dose prefilled syringe by Cipla USA Inc. It indicates this is a single-dose syringe for subcutaneous or intravenous use. The label includes ingredients, storage instructions, manufacturer info, and dosage form details, with a clear branding and dose strength on the package.*

FDA Label Image

480mcg (10) 0.8 mL Syringe Carton. (480mcg (10) 0.8 mL Syringe Carton)

Packaging label for NYPOZI (filgrastim-txid) injection, 480 mcg/0.8 mL, in single-dose prefilled syringes. The label includes product name, strength, dosage form, and manufacturer Cipla USA Inc. It indicates use for subcutaneous or intravenous injection with instructions for dilution, storage, and handling. The package contains 10 prefilled syringes with needle guards.*

FDA Label Image

Cipla Logo. (Cipla Logo)

FDA Label Image

Nypozi-01. (Nypozi 01)

Illustration of a syringe device before and after use, showing labeled components such as the gray needle cap, needle guard, dose markings, plunger with conical base and stopper, viewing window with label for expiration date and lot number, finger grips, needle guard wings, and plunger head. The diagram demonstrates the needle guard extension and plunger head position changes post-use.*

FDA Label Image

Nypozi-02. (Nypozi 02)

An instructional illustration showing a hand holding a syringe with a needle guard. Arrows indicate to grab the needle guard, suggesting a step in the preparation or safety procedure for administering the NYPOZI injection (filgrastim-txid).*

FDA Label Image

Nypozi-03. (Nypozi 03)

An instructional illustration of a prefilled syringe of NYPOZI (filgrastim-txid) injection showing key components such as a gray needle cap, dose markings on the barrel up to 0.5 mL, a viewing window on the label with expiration date and lot number, and the syringe plunger and finger grips.*

FDA Label Image

Nypozi-04. (Nypozi 04)

An illustration showing a cross-sectional view of a prefilled syringe for the NYPOZI injection containing filgrastim-txid. The syringe is marked with volume graduations up to 0.5 mL, and space is provided for lot and expiration date information. The internal plunger and needle components are visible.*

FDA Label Image

Nypozi-05. (Nypozi 05)

An instructional diagram illustrating five items commonly associated with injection use: a syringe, an alcohol wipe, a cotton ball, an adhesive bandage, and a sharps disposal container with a biohazard symbol. Each item is labeled clearly below its image.*

FDA Label Image

Nypozi-06. (Nypozi 06)

An instructional illustration showing recommended injection sites for NYPOZI (filgrastim-txid) injection. The front and back human figures highlight the upper arm, stomach area (abdomen), thigh, and buttocks as suitable areas for intravenous or subcutaneous administration.*

FDA Label Image

Nypozi-07. (Nypozi 07)

An instructional illustration showing hands removing the protective cap from the needle of a syringe labeled "Syringe barrel," followed by disposal of the used needle into a labeled sharps container. The diagram emphasizes safe handling and disposal of the injection syringe for NYPOZI (filgrastim-txid).*

FDA Label Image

Nypozi-08. (Nypozi 08)

FDA Label Image

Nypozi-09. (Nypozi 09)

An instructional illustration showing the correct technique to use a prefilled syringe injection device. The image depicts hands holding and operating the syringe, focusing on needle placement and injection steps, but does not specify the medication brand or dosage.*

FDA Label Image

Nypozi-10. (Nypozi 10)

Illustration showing how to set a partial dose on the NYPOZI filgrastim-txid injection syringe. It depicts a hand holding the syringe with an arrow indicating upward movement, alongside two detailed close-ups of the syringe dial. Step 1 shows the initial position with dose lines, and Step 2 shows the dial after adjusting to the desired partial dose.*

FDA Label Image

Nypozi-11. (Nypozi 11)

An instructional illustration showing a hand pinching the skin near the lower abdomen with two fingers, indicated by black arrows, likely demonstrating a technique related to subcutaneous injection site preparation.*

FDA Label Image

Nypozi-12. (Nypozi 12)

Instructional diagram showing the correct angle for subcutaneous injection of NYPOZI (filgrastim-txid). It depicts a hand holding a syringe with a needle inserted at approximately 45 degrees into the skin, highlighting the proper injection technique for administration.*

FDA Label Image

Nypozi-13. (Nypozi 13)

An instructional line drawing showing a hand holding a small injection device or syringe with an arrow indicating the action of pressing the device, and another hand positioned to receive the injection or to assist. The image appears to be an injection use or administration guide for the drug NYPOZI (filgrastim-txid).*

FDA Label Image

Nypozi-14. (Nypozi 14)

An instructional illustration showing a hand holding a prefilled syringe labeled NYPOZI with the needle aimed above the skin on another forearm, indicating preparation for subcutaneous injection.*

FDA Label Image

Nypozi-15. (Nypozi 15)

FDA Label Image

Nypozi-16. (Nypozi 16)

An instructional illustration showing a hand holding a prefilled syringe, presumably of NYPOZI injection containing filgrastim-txid. The syringe is held with thumb and fingers, ready for administration via intravenous or subcutaneous route as indicated in the product data.*

FDA Label Image

Nypozi-17. (Nypozi 17)

Illustration showing a hand disposing of a syringe into a container labeled "SHARPS" with a biohazard symbol. The image demonstrates the proper disposal of used syringes into a sharps container for safety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.